Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Race Oncology Ltd. ( (AU:RAC) ) has provided an announcement.
Race Oncology Ltd announced the quotation of 1,295,909 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 9, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially improve its market position, offering stakeholders an opportunity to engage with its growth trajectory.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, primarily focused on developing and commercializing cancer therapies. The company is known for its innovative approaches to oncology treatment and aims to address unmet medical needs in the cancer treatment market.
Average Trading Volume: 369,828
Technical Sentiment Signal: Buy
Current Market Cap: A$684.8M
Learn more about RAC stock on TipRanks’ Stock Analysis page.